Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -10,936 | 117,699 | 210,166 | 185,184 | 127,907 |
Depreciation Amortization | 58,834 | 71,955 | 72,182 | 68,811 | 55,206 |
Income taxes - deferred | 20,655 | 23,377 | 44,582 | -26,560 | 13,466 |
Accounts receivable | -26,727 | -14,230 | -18,030 | 2,114 | -24,146 |
Accounts payable and accrued liabilities | -15,816 | 4,894 | -4,353 | 1,941 | -11,329 |
Other Working Capital | -63,207 | -105,044 | -131,018 | 26,222 | -31,356 |
Other Operating Activity | 174,385 | 34,632 | 15,364 | 31,240 | 72,252 |
Operating Cash Flow | $137,188 | $133,283 | $188,893 | $288,952 | $202,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -6,943 | -16,687 | -5,619 | -875 | -210 |
PPE Investments | -5,484 | -6,099 | -6,158 | -5,252 | -7,278 |
Net Acquisitions | 47,437 | -71,952 | -269,965 | -298,958 | -345,460 |
Sale Of Investment | N/A | N/A | N/A | 17,876 | N/A |
Other Investing Activity | 54 | 252 | 135 | 101 | 0 |
Investing Cash Flow | $35,064 | $-94,486 | $-281,607 | $-287,108 | $-352,948 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 23,000 | 534,500 | 500,700 | 684,200 | 262,500 |
Debt Issued | N/A | N/A | 290,312 | N/A | 175,000 |
Debt Repayment | -76,013 | -13,296 | -9,143 | -10,249 | -5,624 |
Common Stock Issued | 2,702 | 6,152 | 6,022 | 9,887 | 6,798 |
Common Stock Repurchased | -6,529 | -25,332 | -116,776 | -54,493 | -9,556 |
Other Financing Activity | -30,682 | -532,457 | -615,989 | -644,322 | -201,909 |
Financing Cash Flow | $-87,522 | $-30,433 | $55,126 | $-14,977 | $227,209 |
Beginning Cash Position | 54,133 | 45,769 | 83,357 | 96,490 | 20,229 |
End Cash Position | 138,863 | 54,133 | 45,769 | 83,357 | 96,490 |
Net Cash Flow | $84,730 | $8,364 | $-37,588 | $-13,133 | $76,261 |
Free Cash Flow | |||||
Operating Cash Flow | 137,188 | 133,283 | 188,893 | 288,952 | 202,000 |
Capital Expenditure | -5,620 | -6,165 | -6,302 | -5,332 | -7,888 |
Free Cash Flow | 131,568 | 127,118 | 182,591 | 283,620 | 194,112 |